Healthcare Infection Control Practices Advisory Committee (HICPAC), 4820 [2012-2001]
Download as PDF
<![CDATA[
4820
Federal Register / Vol. 77, No. 20 / Tuesday, January 31, 2012 / Notices
Keith A. Tucker,
Paperwork Reduction Act Clearance Officer,
Office of the Secretary.
[FR Doc. 2012–2038 Filed 1–30–12; 8:45 am]
BILLING CODE 4150–36–P
Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–2001 Filed 1–30–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention
wreier-aviles on DSK5TPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory
Committee), National Institute for
Occupational Safety and Health
(NIOSH)
Times and Dates: 9 a.m.–5 p.m., February
16, 2012, 9 a.m.–12 p.m., February 17, 2012.
Place: CDC, Global Communications
Center, Building 19, Auditorium B3, 1600
Clifton Road NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health
and Human Services, the Director, CDC, the
Director, National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), and
the Director, Division of Healthcare Quality
Promotion regarding (1) the practice of
healthcare infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: The agenda will
include updates on CDC’s activities for
Healthcare Associated Infections (HAI),
CDC’s dialysis HAI activities, and CDC’s
long-term care HAI activities, draft guideline
for prevention of infections among patients
in neonatal intensive care units (NICU), draft
guideline for infection control in healthcare
personnel, draft guideline for the prevention
of surgical site infections, update from the
HICPAC surveillance working group, and
updates on HAI surveillance definitions.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, l600
Clifton Road NE., Mailstop A–07, Atlanta,
Georgia 30333, Telephone: (404) 639–8692,
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meetings of the
aforementioned committee:
VerDate Mar<15>2010
15:20 Jan 30, 2012
Jkt 226001
Committee Public Meeting Times and
Dates: (All times are Eastern Standard Time.)
12 p.m.–5 p.m., February 15, 2012. 8:30
a.m.–2 p.m., February 16, 2012.
Public Comment Times and Dates: (All
times are Eastern Standard Time.)
3:45 p.m.–4:45 p.m., on February 15, 2012.
8:45 a.m.–9:45 a.m., on February 16, 2012.
Place: Jacob J. Javits Federal Building, 26
Federal Plaza, New York, New York 10278.
This meeting is also available by
teleconference. Please dial 1–800–593–0693
and enter code 37121.
Status: Open to the public, limited by the
capacity of the room, which is about 70
persons, and the number of telephone lines.
The conference line will accommodate up to
300 callers; therefore it is suggested that
those interested in calling in to listen to the
committee meeting share a line when
possible.
Please note that the public comment
periods end at the times indicated above or
following the last call for comments,
whichever is earlier. Members of the public
who want to comment must sign up. A
limited number of time slots are available
and will be assigned on a first come-first
served basis. Each commenter will be
provided up to five minutes for comment.
You can sign up before the meeting by mail,
facsimile, email, or telephone until all slots
are filled. When you sign up you must
indicate if you will be making your
comments by telephone or in person.
Advance sign up will conclude at 5 p.m. on
February 13, 2012. If time slots are still
available, you will be able to sign up at the
meeting beginning at 11 a.m. on February 15
for the public comment period that day, or
beginning at 8 a.m. on February 16, for the
public comment period that day. To sign up
in advance of the meeting, use the contact
information that follows.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Mail: NIOSH Docket Office, Robert A. Taft
Laboratories, MS–C–34, 4676 Columbia
Parkway, Cincinnati, Ohio 45226.
Facsimile: (513) 533–8285.
Email: nioshdocket@cdc.gov.
Telephone: (513) 533–8611.
Written comments will also be accepted
(see below).
Security Considerations: Due to mandatory
security clearance procedures at the Jacob K.
Javits Federal Building, in-person attendees
must present valid government-issued
picture identification to security personnel
upon entering the building and go through an
airport-type security check. Non-U.S. citizens
are encouraged to participate in the audio
conferencing due to the extra clearance
involved with in-person attendance. To
attend in person, a non-U.S. citizen will have
to call or send an email to the contact person
in this Notice before February 1, 2012, and
provide passport information. You will be
notified if clearance to attend the meeting in
person is received; otherwise, you will not be
able to attend the meeting in person.
Background: The Advisory Committee was
established by Public Law 111–347 (The
James Zadroga 9/11 Health and
Compensation Act of 2010, Title XXXIII of
the Public Health Service Act), enacted on
January 2, 2011 and codified at 42 U.S.C.
300mm–300mm–61.
Purpose: The purpose of the Advisory
Committee is to review scientific and
medical evidence and to make
recommendations to the World Trade Center
(WTC) Program Administrator regarding
additional WTC Health Program eligibility
criteria and potential additions to the list of
covered WTC-related health conditions. Title
XXXIII of the Public Health Service Act
established within the Department of Health
and Human Services (HHS), the World Trade
Center (WTC) Health Program, to be
administered by the WTC Program
Administrator. The WTC Health Program
provides: (1) Medical monitoring and
treatment benefits to eligible emergency
responders and recovery and cleanup
workers (including those who are Federal
employees) who responded to the September
11, 2001, terrorist attacks, and (2) initial
health evaluation, monitoring, and treatment
benefits to residents and other building
occupants and area workers in New York
City, who were directly impacted and
adversely affected by such attacks
(‘‘survivors’’). Certain specific activities of
the WTC Program Administrator are reserved
to the Secretary, HHS, to delegate at her
discretion; other WTC Program
Administrator duties not explicitly reserved
to the Secretary, HHS, are assigned to the
Director, NIOSH. The administration of the
Advisory Committee established under
Section 300mm–1(a) is left to the Director of
NIOSH in his role as WTC Program
Administrator. CDC and NIOSH provide
funding, staffing, and administrative support
services for the Advisory Committee. The
charter was issued on May 12, 2011, and will
expire on May 12, 2013.
Matters To Be Discussed: The agenda for
the Advisory Committee meeting includes:
discussion of the petition to add cancer to the
list of covered WTC-related health
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 77, Number 20 (Tuesday, January 31, 2012)]
[Notices]
[Page 4820]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-2001]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting for the aforementioned
committee:
Times and Dates: 9 a.m.-5 p.m., February 16, 2012, 9 a.m.-12
p.m., February 17, 2012.
Place: CDC, Global Communications Center, Building 19,
Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health and
Human Services, the Director, CDC, the Director, National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID), and the
Director, Division of Healthcare Quality Promotion regarding (1) the
practice of healthcare infection control; (2) strategies for
surveillance, prevention, and control of infections (e.g.,
nosocomial infections), antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating
of guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Discussed: The agenda will include updates on
CDC's activities for Healthcare Associated Infections (HAI), CDC's
dialysis HAI activities, and CDC's long-term care HAI activities,
draft guideline for prevention of infections among patients in
neonatal intensive care units (NICU), draft guideline for infection
control in healthcare personnel, draft guideline for the prevention
of surgical site infections, update from the HICPAC surveillance
working group, and updates on HAI surveillance definitions.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30333, Telephone: (404)
639-8692, Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-2001 Filed 1-30-12; 8:45 am]
BILLING CODE 4163-18-P
